Kenfarb & Co’s Herbalife HLF Stock Holding History

Kenfarb & Co’s Portfolio HLF Stock Details HLF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$2.8K	Hold	200	–	–	﹤0.01%	208
2023 Q2	$2.65K	Hold	200	–	–	﹤0.01%	209
2023 Q1	$3.22K	Hold	200	–	–	﹤0.01%	208
2022 Q4	$2.98K	Hold	200	–	–	﹤0.01%	223
2022 Q3	$4K	Buy	+200	New	+$4.95K	﹤0.01%	217

Other funds holding HLF

ROIC

Route One Investment Company San Francisco, California $2.35B AUM 11.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WPL

WINDACRE PARTNERSHIP LLC Houston, Texas $9.34B AUM 17.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BCM

Bronte Capital Management Bondi Junction, Australia $1.01B AUM 47.99% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Kenfarb & Co's HLF Position: Q3 2023 in Review

Kenfarb & Co held its Herbalife (HLF) position steady in Q3 2023 at 200 shares worth $2.8K. The position accounts for ﹤0.01% of the portfolio, ranked #208.

Kenfarb & Co first reported a position in HLF in Q3 2022 and has held it in 5 quarters since. The position peaked at $4K in Q3 2022. 197 funds tracked by Wall St. Rank hold HLF as of Q3 2023.

Kenfarb & Co held 200 shares of Herbalife worth $2.8K as of Q3 2023.
Kenfarb & Co left its Herbalife share count unchanged in Q3 2023.
Herbalife made up ﹤0.01% of Kenfarb & Co's portfolio in Q3 2023, its #208 holding.
Kenfarb & Co first reported a position in Herbalife in Q3 2022 and has held it in 5 quarters since.
Kenfarb & Co's Herbalife position peaked at $4K in Q3 2022.
197 funds tracked by Wall St. Rank held Herbalife as of Q3 2023.

Based on Kenfarb & Co's 13F filing for Q3 2023, filed 14 Nov 2023.